Author
C. J. Stocks
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2021-2023 · peak 1/yrCo-Author Collaboration Network
10 top collaborators · 35 mutual co-author links3 papers
Recent·Most cited
Macrophages only sense infectious SARS-CoV-2 when they express sufficient ACE2 to permit viral entry, where rapid cytokine responses then limit viral replication.
L. I. Labzin, K. Y. Chew, K. Eschke, X. Wang, T. Esposito, C. J. Stocks, J. Rae, R. Patrick, H. Mostafavi, B. Hill, T. Yordanov, C. L. Holley, S. Emming, S. Fritzlar, F. L. Mordant, , K. Schroder
The paper shows that ACE2-expressing macrophages allow SARS-CoV-2 entry and replication, triggering anti-viral responses, while ACE2-negative macrophages do not support viral entry or cytokine release.
bioRxiv · Mar 22, 2022 · PreprintImmunology
Pediatric nasal epithelial cells are less permissive to SARS-CoV-2 replication compared to adult cells
Y. Zhu, K. Y. Chew, M. Wu, A. C. Karawita, G. McCallum, L. E. Steele, A. Yamamoto, L. L. Labzin, T. Yarlagadda, A. A. Khromykh, X. Wang, J. Sng, C. J. Stocks, Y. Xia, T. R. Kollmann, , K. R. Short
The paper compares SARS-CoV-2 replication in pediatric and adult nasal epithelial cells, finding lower viral titers in children for ancestral and Delta variants, but higher replication for Omicron.
bioRxiv · Mar 8, 2021 · PreprintMicrobiology